Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway

Oncotarget

Volumn 7, Issue 9, 2016, Pages 9939-9950

  Su, Xuan ^a   Wang, Jianning ^b   Chen, Weichao ^a   Li, Zhaoqu ^a   Fu, Xiaoyan ^a   Yang, Ankui ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Aggressiveness; NF B pathway; TRIM14; TSCC

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; TRIPARTITE MOTIF PROTEIN 14; UNCLASSIFIED DRUG; CARRIER PROTEIN; TRIM14 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENICITY; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; MULTIVARIATE ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; THERAPY EFFECT; TONGUE CARCINOMA; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHICK EMBRYO; DISEASE COURSE; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CHICK EMBRYO; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TONGUE NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84961613438     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6941     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA: a cancer journal for clinicians 2007;57:43-66.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: Globocan 2008. International journal of cancer 2010;127:2893-2917.
3. Argiris A, Karamouzis MV, Raben D, Ferris RL: Head and neck cancer. Lancet 2008;371:1695-1709.
4. Scully C, Bagan JV: Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes. Oral oncology 2009;45:e25-30.
5. Bello IO, Soini Y, Salo T: Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (ii). Oral oncology 2010;46:636-643.
6. Bello IO, Soini Y, Salo T: Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (i). Oral oncology 2010;46:630-635.
7. Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C: Nuclear factor-κb is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer research;64:6511-23.
8. Wang Y, Lin Z, Sun L, Fan S, Huang Z, Zhang D, Yang Z, Li J, Chen W: Akt/ezrin tyr353/nf-kappab pathway regulates egf-induced emt and metastasis in tongue squamous cell carcinoma. British journal of cancer 2014;110:695-705.
9. Yao J, Duan L, Fan M, Wu X: Nf-kappab signaling pathway is involved in growth inhibition, g2/m arrest and apoptosis induced by trichostatin a in human tongue carcinoma cells. Pharmacological research: 2006;54:406-413.
10. Lu KW, Tsai ML, Chen JC, Hsu SC, Hsia TC, Lin MW, Huang AC, Chang YH, Ip SW, Lu HF, Chung JG: Gypenosides inhibited invasion and migration of human tongue cancer scc4 cells through down-regulation of nfkappab and matrix metalloproteinase-9. Anticancer research 2008;28:1093-1099.
11. Peng B, Gu Y, Xiong Y, Zheng G, He Z: Microarrayassisted pathway analysis identifies mt1x & nfkappab as mediators of tcrp1-associated resistance to cisplatin in oral squamous cell carcinoma. PloS one 2012;7:e51413.
12. Meroni G, Diez-Roux G: Trim/rbcc, a novel class of 'single protein ring finger' e3 ubiquitin ligases. BioEssays: news and reviews in molecular, cellular and developmental biology 2005;27:1147-1157.
13. Nenasheva VV, Kovaleva GV, Khaidarova NV, Novosadova EV, Manuilova ES, Antonov SA, Tarantul VZ: Trim14 overexpression causes the same transcriptional changes in mouse embryonic stem cells and human hek293 cells. In vitro cellular & developmental biology Animal 2014;50:121-128.
14. Kimsa MW, Strzalka-Mrozik B, Kimsa MC, Mazurek U, Kruszniewska-Rajs C, Gola J, Adamska J, Twardoch M: Differential expression of tripartite motif-containing family in normal human dermal fibroblasts in response to porcine endogenous retrovirus infection. Folia biologica 2014;60:144-151.
15. Nenasheva VV, Kovaleva GV, Uryvaev LV, Ionova KS, Dedova AV, Vorkunova GK, Chernyshenko SV, Khaidarova NV, Tarantul VZ: Enhanced expression of trim14 gene suppressed sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity. Immunologic research 2015;62:255-262.
16. Zhou Z, Jia X, Xue Q, Dou Z, Ma Y, Zhao Z, Jiang Z, He B, Jin Q, Wang J: Trim14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-i-like receptor-mediated innate immune response. Proceedings of the National Academy of Sciences of the United States of America 2014;111:E245-254.
17. Hoesel B, Schmid JA: The complexity of nf-kappab signaling in inflammation and cancer. Molecular cancer 2013;12:86.
18. DiDonato JA, Mercurio F, Karin M: Nf-kappab and the link between inflammation and cancer. Immunological reviews 2012;246:379-400.
19. He D, Xu Q, Yan M, Zhang P, Zhou X, Zhang Z, Duan W, Zhong L, Ye D, Chen W: The nf-kappa b inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC cancer 2009;9:343.
20. Staudt LM: Oncogenic activation of nf-kappab. Cold Spring Harbor perspectives in biology 2010;2:a000109.
21. Hatakeyama S: Trim proteins and cancer. Nature reviews Cancer 2011;11:792-804.
22. Jiang T, Tang HM, Lu S, Yan DW, Yang YX, Peng ZH: Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer. Medical oncology 2013;30:715.
23. Cambiaghi V, Giuliani V, Lombardi S, Marinelli C, Toffalorio F, Pelicci PG: Trim proteins in cancer. Advances in experimental medicine and biology 2012;770:77-91.
24. Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, Tanaka F, Watanabe M, Mori M: Tripartite motif-containing 29 (trim29) is a novel marker for lymph node metastasis in gastric cancer. Annals of surgical oncology 2007;14:2543-2549.
25. Hawthorn L, Stein L, Panzarella J, Loewen GM, Baumann H: Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung cancer 2006;53:129-142.
26. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Jr., Pecorelli S: Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. International journal of cancer 2004;112:14-25.
27. Horn EJ, Albor A, Liu Y, El-Hizawi S, Vanderbeek GE, Babcock M, Bowden GT, Hennings H, Lozano G, Weinberg WC, Kulesz-Martin M: Ring protein trim32 associated with skin carcinogenesis has anti-apoptotic and e3-ubiquitin ligase properties. Carcinogenesis 2004;25:157-167.
28. Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S: Trim68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer research 2008;68:3486-3494.
29. Li Q, Yan J, Mao AP, Li C, Ran Y, Shu HB, Wang YY: Tripartite motif 8 (TRIM8) modulates TNFα-and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination. Proceedings of the National Academy of Sciences of the United States of America 2011;108:19341-19346.
30. Yu S, Gao B, Duan Z, Xu W, Xiong S: Identification of tripartite motif-containing 22 (trim22) as a novel nf-kappab activator. Biochemical and biophysical research communications 2011;410:247-251.
31. Zhou Z, Jia X, Xue QH, Dou ZX, Ma YJ, Zhao ZD, Jiang ZF, He B, Jin Q, Wang JW: Trim14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-i-like receptor-mediated innate immune response. Proceedings of the National Academy of Sciences of the United States of America 2014;111:E245-E254.
32. Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P: Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension 2002;39:224-228.